Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

National Institutes of Health (NIH)

Dr. Norman Sharpless Sworn in as Director of the National Cancer Institute

Dr. Norman “Ned” Sharpless

Bethesda, MD, October 19, 2017 — Norman E. “Ned” Sharpless, M.D., took the oath of office October 17 to become the 15th director of the National Cancer Institute (NCI), part of the National Institutes of Health. H

Dr. Sharpless succeeds Harold E. Varmus, M.D., who stepped down as director in March 2015. Douglas R. Lowy, M.D., has been NCI’s acting director since April 2015.

“It is an honor to welcome Dr. Sharpless to the Department of Health and Human Services and the National Institutes of Health,” said Acting Health and Human Services Secretary Eric D. Hargan. Continue reading

NIH Accelerates the Use of Genomics Sequencing in Clinical Care

Bethesda, MD, October 13, 2017 — The National Institutes of Health (NIH) on August 8 announced it is awarding $18.9 million towards research that aims to accelerate the use of genome sequencing in clinical care.

The new awards will generate innovative approaches and best practices to ensure that the effectiveness of genomic medicine can be applied to all individuals and groups, including diverse and underserved populations, and in healthcare settings that extend beyond academic medical centers. Continue reading

Gov. Christie, Pharma Executives and Federal Leaders Discuss Public-Private Partnership to Address Opioid Epidemic

Governor Chris Christie

Trenton, NJ, September 19, 2017 — Governor Chris Christie, chairman of the President’s Commission on Combating Drug Addiction and the Opioid Crisis, yesterday joined Kellyanne Conway, Counselor to the President, and Former U.S. Rep. Patrick Kennedy, a commission member, in a roundtable at the War Memorial with leaders of the pharmaceutical industry, the National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) to advance a public-private partnership that can address America’s epidemic of addiction.

Governor Christie said, “The public and private sectors must join together to address this public health crisis and act quickly to stop an epidemic delivering a death toll equivalent to America enduring another 9-11 attack every two and a half weeks.” Continue reading

Congress Rejects President’s Proposals to Cut Health NIH Research Funds

Washington, DC, September 12, 2017 — Robert Pear reports in The New York Times that, back in March, when President Donald J. Trump released the first draft of his budget proposal for the coming fiscal year, he asked lawmakers for deep cuts to one of their favorite institutions, the National Institutes of Health (NIH) — part of a broad reordering of priorities, away from science and social spending, toward defense and border security.

Six months later, Congress has not only rejected the president’s NIH’s proposal, lawmakers from both parties have joined forces to increase spending on biomedical research — and have bragged about it. Continue reading

Senate Appropriators Approve $2 Billion Raise for NIH in 2018

Washington, DC, September 8, 2017 — Lev Facher reports on STAT that the U.S. Senate appropriators on September 7 approved a plan that would increase spending for the National Institutes of Health (NIH) by $2 billion and maintain nearly $300 million in grants for family planning programs that a House committee had sought to eliminate.

The plan would also fund the Substance Abuse and Mental Health Services Administration (SAMHSA) by $387 million more than the amount recommended by President Trump’s budget blueprint.

The bill approved by the Senate Appropriations Committee is perhaps a best-case scenario for boosters of the NIH, family planning advocates, and those fighting the opioid crisis. Continue reading

NIH to Walk Away from $16 Million of NFL Gift for Brain Research

Washington, DC, September 1, 2017The Los Angeles Times reported in July that, five years ago, four months after the suicide of legendary linebacker Junior Seau, the National Football League donated $30 million to the National Institutes of Health (NIH) for brain research.

At the time, the league said its “unrestricted gift” was the largest donation in its history and would help fund a new Sports and Health Research Program to be conducted in collaboration with institutes and centers at the NIH. Continue reading

California Received Largest NIH Awards Between 2007-2016; New Jersey Award Funding Decreased

Bethesda, MD, August 5, 2017 — The State Science & Technology Institute (SSTI) news blog reports that, with a focus on improving health, driving economic growth, and expanding the country’s research capacity, the National Institutes of Health (NIH) is the largest public funder of biomedical research in the world.

Because of NIH’s central role in supporting science, technology, and innovation, a better understanding of the agency’s footprint may be helpful to the technology-based economic development practitioner community.

This edition of Useful Stats utilizes data from NIH’s Research Portfolio Online Reporting Tool (RePORT) and covers each year from 2007 to 2016. The data does not include projects funded by the American Recovery and Reinvestment Act of 2009. Continue reading

Patients and Families Make Emotional Plea at Senate Hearing for Diabetes Research Funding

Washington, DC, July 27, 2017 — Summer Park reports on Roll Call that families and advocates delivered an emotional plea for more diabetes research funding before Congress on July 26.

People with type 1 diabetes, including over 160 children, were on hand for a hearing before the Senate Special Committee on Aging.

Those testifying urged lawmakers to extend the Special Diabetes Program, which funds research into type 1 diabetes.  The program will run out of funds this September if lawmakers don’t act. Continue reading

U.S. House Subcommittee Defies Trump’s Budget and Proposes $1.1 Billion Boost for NHI

Washington, DC, July 13, 2017 — Rachel Roubein reports in The Hill that the U.S. House of Representatives subcommittee controlling the purse strings of the National Institutes of Health (NIH) on July 12 proposed a $1.1 billion boost for the agency, defying the Trump administration’s push for cuts.

The White House had proposed slashing the nation’s medical research agency by $5.8 billion.

But it was clear from the get-go that Congress wouldn’t support cutting NIH’s budget, with members of both parties in opposition. Continue reading

National Institute on Aging Report: Promising But Inconclusive Evidence on Interventions to Prevent Cognitive Decline, Dementia

Bethesda, MD, June 23, 2017 — The public is enormously concerned about dementia and cognitive impairment, and a wide range of programs and products, such as diets, exercise regimens, games, and supplements, purport to keep these conditions at bay.

It is difficult for individuals, health care providers and policy makers to ascertain what has been demonstrated to prevent or reduce risk.

To help sort through the data and to understand the quality and weight of current evidence for possible interventions, the National Institute on Aging (NIA) at the National Institutes of Health (NIH), commissioned experts for an extensive scientific review and to provide recommendations for public health messaging and future research priorities. Continue reading